Blends & StacksUpdated July 25, 2026 · Educational reference

NAD+ + MOTS-C + 5-Amino-1MQ: The Mitochondrial Blend

Also known as: NAD+ + MOTS-C + 5-Amino-1MQ · Metabolic longevity blend · NAD/MOTS-C/5-Amino blend

ClassPre-mixed blend — mitochondrial / metabolic
ComponentsNAD+ + MOTS-C + 5-Amino-1MQ
Typical doseNo established protocol; ratios vary widely by seller
Half-lifeDiffers per component and is poorly characterised for two of the three
Typical routeSubQ
Combination evidenceNone. Two of the three components have essentially no human efficacy data
Quick answer

Three compounds grouped under a mitochondrial and metabolic theme. NAD+ is a coenzyme central to cellular energy metabolism whose levels decline with age. MOTS-C is a mitochondrial-derived peptide studied in animals for metabolic and exercise-mimetic effects. 5-Amino-1MQ is an NNMT inhibitor investigated preclinically for fat metabolism. The theme is coherent; the evidence is not there. Two of the three have essentially no human efficacy data, and the combination has never been studied. Educational only, not medical advice.

What each component is

NAD+ (nicotinamide adenine dinucleotide) is a genuinely important coenzyme — it is not a fringe compound, and the age-related decline in NAD+ is a real and well-documented phenomenon. What is much less settled is whether supplementing it, and by what route, produces meaningful clinical outcomes in humans. Most human work has used oral precursors such as NR and NMN rather than injected NAD+, with results that have been modest and mixed.

MOTS-C is a peptide encoded in mitochondrial DNA, described in animal work as improving insulin sensitivity and exercising a kind of exercise-mimetic effect on metabolism. The animal data is interesting. Human efficacy data is essentially absent.

5-Amino-1MQ inhibits NNMT, an enzyme implicated in fat-cell metabolism, and has preclinical work suggesting effects on fat mass in rodents. Human data is absent.

Why the blend is hard to reason about

Three compounds, at unstandardised ratios, two of which have no human efficacy evidence, combined on a thematic rather than a mechanistic rationale. "All three relate to mitochondria and metabolism" is a category, not a synergy argument — unlike the GHRH-plus-GHRP pairing, there is no proposed mechanism by which these three specifically potentiate each other.

Injected NAD+ also has a distinctive practical property worth knowing before you try it: it is commonly reported to cause significant discomfort, flushing and a chest-tightness sensation during administration, particularly if given quickly. That is well known among people who use it and is the main reason infusions are given slowly.

How to track NAD+ + MOTS-C + 5-Amino-1MQ in Stackeddd

This blend is marketed on feel — energy, clarity, recovery — which are the easiest outcomes to imagine. If you want to know whether it does anything, pick something countable before you start: resting heart rate, sleep efficiency, a repeatable workout benchmark.

Model it yourself · free, no account

Reconstitution Calculator

A blend is one reconstitution that sets the dose of every compound in the vial — get the water volume right once and every draw after it is correct.

Related compounds

Related reading: What peptides can you mix in the same syringe? · Peptide reconstitution math: how much BAC water to add

Frequently asked questions

Does injected NAD+ work?

The age-related decline in NAD+ is real and well documented. Whether supplementing it produces meaningful clinical outcomes in humans is much less settled — most human research has used oral precursors like NR and NMN rather than injections, with modest and mixed results.

Why does NAD+ injection feel unpleasant?

Significant flushing, chest tightness and general discomfort during administration are commonly reported, and are worse when it is given quickly. It is the main reason NAD+ infusions are administered slowly.

Is there a reason these three are combined?

They share a theme — mitochondrial and metabolic function — rather than a mechanism. Unlike pairings such as GHRH plus GHRP, there is no proposed pathway by which these three specifically potentiate one another, and the combination has not been studied.

This is educational information, not medical advice. Doses and protocols above reflect published references and community practice — protocol decisions belong with your prescribing physician. Generic names used throughout. How this reference is built & how the AI is tested →

STACKEDDD

Track it instead of guessing.

Doses, reconstitution, bloodwork, and an AI coach grounded in your own data — free to start, on the App Store and Google Play.

App StoreGoogle Play

← Back to the compound library